WaveSense Europe Launches Jazz™ Glucose Meter for Diabetes in UK
Glasgow, United Kingdom, March 5, 2008 – WaveSense Europe announces the launch of the WaveSense Jazz™ Blood Glucose Monitoring System (BGMS) at the 2008 Diabetes UK meeting in Glasgow, Scotland. The WaveSense Jazz™ blood glucose meter (BGM) has market-leading features designed to help people with diabetes gain tighter control over their blood glucose levels.
In addition to requiring no code and having some of the world’s largest backlit digits on a BGM, the Jazz is one of the first meters to provide a glycemic variability value. Glycemic variability is a tool used to show how glucose changes over time and may allow the patient or their health care professional to better analyze high and low readings and take preventative action.
“I’m thrilled to bring our flagship product to the UK diabetes community,” said Claudio Carboni, Managing Director of WaveSense Europe Ltd. “This market demands innovative, high accuracy, and high quality BGM products and I feel that WaveSense Jazz is well-positioned to advance the quality of diabetes care.”
Like all the company’s BGM systems, Jazz features WaveSense, a new technology that personalizes each test to provide world class accuracy. WaveSense detects and corrects for errors caused by different environmental conditions and blood samples.
“There’s plenty of research showing the need for improved glucose control, especially for those on insulin,” said Dave Conn, Chief Commercial Officer of WaveSense and former President and CEO of Hypoguard (LSE: MDY). “WaveSense technology finally gives those with diabetes the accurate glucose measurements they need to act with more confidence.”
Other market leading features in the WaveSense Jazz include:
• Wireless version: A special wireless version has Bluetooth® connectivity for automatic, secure transfer of glucose results.
• Predictive mealtime tagging: Smart pre- and post- meal tagging (breakfast, lunch, dinner, and nighttime) allows the patient to easily tag their results based on their personal schedule without having to go through complex menus and navigation.
• Positive feedback: Alerts the user if their blood glucose result is within their pre- and post-meal target range to encourage tighter control. The ranges can be easily changed by the user or their healthcare professional.
• Very large memory: 1,865 memories for an average of over 5 memories/day for a year.
For more information on WaveSense, see www.wavesense.co.uk or contact firstname.lastname@example.org
© 2002-2008 AgaMatrix, Inc. WaveSense; the WaveSense logo; and Jazz are trademarks of AgaMatrix, Inc. All other trademarks and copyrights are the properties of their respective owners.